Видео ютуба по тегу Sernova Cell Pouch

Sernova’s Cell Pouch System tackles diabetes
Sernova’s Cell Pouch System tackles diabetes
Whiteboard: Sernova's Cell Pouch™ for Type 1 Diabetes (T1D)
Whiteboard: Sernova's Cell Pouch™ for Type 1 Diabetes (T1D)
Sernova's BREAKTHROUGH Cell Pouch Fights Type-1 Diabetes!
Sernova's BREAKTHROUGH Cell Pouch Fights Type-1 Diabetes!
Great T1D Cell Pouch Results From Sernova for Islet Cell Transplantation
Great T1D Cell Pouch Results From Sernova for Islet Cell Transplantation
Sernova reported findings that further validate Cell Pouch™ and therapeutic cell performance
Sernova reported findings that further validate Cell Pouch™ and therapeutic cell performance
Sernova Cell Pouch: 5-Year Study Results for Type-1 Diabetics [2024 Update]
Sernova Cell Pouch: 5-Year Study Results for Type-1 Diabetics [2024 Update]
Sernova Global Partnership Family Office Presentation
Sernova Global Partnership Family Office Presentation
Innovating Cell-Based Solutions for Type 1 Diabetes ft. Jonathan Rigby, CEO, Sernova
Innovating Cell-Based Solutions for Type 1 Diabetes ft. Jonathan Rigby, CEO, Sernova
Sernova (TSXV: SVA) “CGM” will be provided to patients for a clinical trial of its Cell Pouch™.
Sernova (TSXV: SVA) “CGM” will be provided to patients for a clinical trial of its Cell Pouch™.
Sernova's Search For A Cure Explained
Sernova's Search For A Cure Explained
Sernova’s Cell Pouch System - An Update on the Path to Insulin Independence
Sernova’s Cell Pouch System - An Update on the Path to Insulin Independence
Sernova FDA Clearance: Cell Pouch for Hypothyroidism Treatment
Sernova FDA Clearance: Cell Pouch for Hypothyroidism Treatment
News Alert: Sernova – Developing a Functional Cure for Type I Diabetes
News Alert: Sernova – Developing a Functional Cure for Type I Diabetes
Sernova Corp. (TSXV: SVA) - 2022 TSX Venture 50
Sernova Corp. (TSXV: SVA) - 2022 TSX Venture 50
Sernova KOL Event on Thyroid Disease and Potential for Cell Therapy as a Novel Treatment Approach
Sernova KOL Event on Thyroid Disease and Potential for Cell Therapy as a Novel Treatment Approach
Sernova
Sernova
Sernova enrolling patients in Phase 1/2 clinical trial for its Cell Pouch device
Sernova enrolling patients in Phase 1/2 clinical trial for its Cell Pouch device
ADA Scientific Sessions Presentation
ADA Scientific Sessions Presentation
"Sernova Reports 2023 Advancements & 2024 Milestones"